<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>DEXPANTHENOL - dexpanthenol injection, solution </strong><br>American Regent, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1><span class="Bold">DEXPANTHENOL INJECTION</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx Only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1><span class="Bold">DESCRIPTION
</span></h1>
<p class="First">Dexpanthenol is a derivative of pantothenic acid, a B complex vitamin. Dexpanthenol Injection is a sterile, nonpyrogenic, aqueous solution indicated for use as a gastrointestinal stimulant. The chemical name is D-(+)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethybutylamide. The structural formula is:</p>
<div class="Figure"><img alt="02298ea1-figure-01" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0ed47f4b-5182-40b7-a440-9e7b06819d95&amp;name=02298ea1-figure-01.jpg"></div>
<p>Each mL contains Dexpanthenol 250 mg in Water for Injection q.s. pH (range 4 - 7) may be adjusted with Sodium Citrate and/or Citric Acid.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY
</span></h1>
<p class="First">Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">adynamic ileus</span>. The pharmacological mode of action of the drug is unknown. Pharmacokinetics data in humans is unavailable.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1><span class="Bold">INDICATIONS AND USAGE
</span></h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">Prophylactic</span> use immediately after major abdominal surgery to minimize the possibility of <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">paralytic ileus</span>. Intestinal atony causing abdominal <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span>; postoperative or postpartum retention of <span class="product-label-link" type="condition" conceptid="4091513" conceptname="Passing flatus">flatus</span>, or postoperative delay in resumption of intestinal motility; <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">paralytic ileus</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS
</span></h1>
<p class="First">There are no known contraindications to the use of Dexpanthenol Injection.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS
</span></h1>
<p class="First">There have been rare instances of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> of unknown cause during the concomitant use of Dexpanthenol Injection with drugs such as antibiotics, narcotics and barbiturates.</p>
<p>Administration of Dexpanthenol Injection directly into the vein is not advised (See <span class="Bold">Dosage and Administration</span>).</p>
<p>Dexpanthenol Injection should not be administered within one hour of succinylcholine.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS
</span></h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-7.1"></a><p></p>
<h2><span class="Italics">General
</span></h2>
<p class="First">If any signs of a <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reaction</span> appear, Dexpanthenol Injection should be discontinued. If <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span> is a secondary consequence of mechanical obstruction, primary attention should be directed to the obstruction.</p>
<p>The management of <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">adynamic ileus</span> includes the correction of any fluid and <span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">electrolyte imbalance</span> (especially <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>), <span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">anemia</span> and <span class="product-label-link" type="condition" conceptid="4228222" conceptname="Hypoproteinemia">hypoproteinemia</span>, treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>, avoidance where possible of drugs which are known to decrease gastrointestinal motility and decompression of the gastrointestinal tract when considerably distended by nasogastric suction or use of a long intestinal tube.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-7.2"></a><p></p>
<h2><span class="Italics">Drug Interactions
</span></h2>
<p class="First">The effects of succinylcholine appeared to have been prolonged in a woman administered dexpanthenol.</p>
<p><span class="Italics">Carcinogenicity, Mutagenicity, and Impairment of Fertility </span>- There have been no studies in animals to evaluate the carcinogenic, mutagenic, or impairment of fertility potential of dexpanthenol.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-7.3"></a><p></p>
<h2><span class="Italics">Pregnancy
</span></h2>
<div class="Section" data-sectionCode="34077-8">
<a name="section-7.3.1"></a><p></p>
<h3><span class="Italics Underline">Teratogenic Effects
</span></h3>
<p class="First">Pregnancy Category C. Animal reproduction studies have not been conducted with Dexpanthenol Injection. It is also not known whether Dexpanthenol Injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Dexpanthenol Injection should be given to a pregnant</p>
<p>woman only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-7.4"></a><p></p>
<h2><span class="Italics">Nursing Mothers
</span></h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Dexpanthenol Injection is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-7.5"></a><p></p>
<h2><span class="Italics">Pediatric Use
</span></h2>
<p class="First">Safety and effectiveness in children have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS
</span></h1>
<p class="First">There have been a few reports of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> and single reports of several other adverse events in association with the administration of dexpanthenol. A causal relationship is uncertain. One patient experienced <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling</span>, difficulty in breathing. Another patient had red patches of skin. Two patients had generalized <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span> and one patient <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>.</p>
<p>One patient experienced temporary respiratory difficulty following administration of dexpanthenol injection 5 minutes after succinylcholine was discontinued.</p>
<p>One patient experienced a noticeable but slight <span class="product-label-link" type="condition" conceptid="314171" conceptname="Low blood pressure reading">drop in blood pressure</span> after administration of dexpanthenol while in the recovery room.</p>
<p>One patient experienced intestinal <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">colic</span> one-half hour after the drug was administered.</p>
<p>Two patients <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomited</span> following administration and two patients had <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> 10 days post-surgery and after Dexpanthenol Injection.</p>
<p>One elderly patient became <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitated</span> after administration of the drug.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-9"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION
</span></h1>
<p class="First">Prevention of post-operative <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">adynamic ileus</span>: 250 mg (1 mL) or 500 mg (2 mL) intramuscularly. Repeat in 2 hours and then every 6 hours until all danger of <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">adynamic ileus</span> has passed.</p>
<p><span class="Italics">Treatment of <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">adynamic ileus</span>: </span>500 mg (2 mL) intramuscularly. Repeat in 2 hours and then every 6 hours as needed.</p>
<p><span class="Italics">Intravenous administration: </span>Dexpanthenol Injection 2 mL (500 mg) may be mixed with bulk I.V. solutions such as glucose or Lactated Ringer’s and slowly infused intravenously.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED
</span></h1>
<p class="First">Dexpanthenol Injection 250 mg/mL</p>
<p>NDC 0517-0131-25        2 mL Single Dose Vial        Packed in boxes of 25</p>
<p>Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) (See USP Controlled Room Temperature).</p>
<p><span class="Bold">AMERICAN</span><span class="Bold"><br></span><span class="Bold">REGENT, INC.</span><span class="Bold"><br></span><span class="Bold">SHIRLEY, NY 11967</span></p>
<p>IN0131</p>
<p>Rev. 1/09</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-11"></a><p></p>
<h1><span class="Bold">PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
</span></h1>
<p class="First">PRINCIPAL DISPLAY PANEL – 2 mL Carton</p>
<p><span class="Bold">DEXPANTHENOL</span><br>INJECTION</p>
<p><span class="Bold">250 mg/mL</span></p>
<p><span class="Bold">NDC 0517-0131-25</span></p>
<p><span class="Bold">25 X 2 mL SINGLE DOSE VIALS</span></p>
<p><span class="Bold">FOR INTRAMUSCULAR USE.</span></p>
<p><span class="Bold">FOR INTRAVENOUS USE AFTER DILUTION.</span></p>
<p><span class="Bold">Rx Only</span></p>
<p>Each mL contains: Dexpanthenol 250 mg in Water for Injection q.s. pH may be adjusted with Sodium Citrate and/or Citric Acid. Sterile, nonpyrogenic. <span class="Bold">WARNING:</span> DISCARD UNUSED PORTION. Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) (See USP Controlled Room Temperature).</p>
<p>Directions for Use: See Package Insert.</p>
<p><span class="Bold">AMERICAN </span><span class="Bold"><br></span><span class="Bold">REGENT, INC.</span><br>SHIRLEY, NY 11967</p>
<p>Rev. 7/06</p>
<div class="Figure"><img alt="02298ea1-figure-02" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0ed47f4b-5182-40b7-a440-9e7b06819d95&amp;name=02298ea1-figure-02.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DEXPANTHENOL 		
					</strong><br><span class="contentTableReg">dexpanthenol injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0517-0131</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS, INTRAMUSCULAR</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DEXPANTHENOL</strong> (DEXPANTHENOL) </td>
<td class="formItem">DEXPANTHENOL</td>
<td class="formItem">250 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM CITRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CITRIC ACID MONOHYDRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0517-0131-25</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">2 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">08/20/1993</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>American Regent, Inc.
							(622781813)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 10/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>02298ea1-b461-4bc9-b426-488d059ed3ea</div>
<div>Set id: 0ed47f4b-5182-40b7-a440-9e7b06819d95</div>
<div>Version: 1</div>
<div>Effective Time: 20111008</div>
</div>
</div> <div class="DistributorName">American Regent, Inc.</div></p>
</body></html>
